South African Clinical Laboratory Products Markets - Growth ...
South African Clinical Laboratory Products Markets - Growth ...
South African Clinical Laboratory Products Markets - Growth ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>South</strong> <strong>African</strong> <strong>Clinical</strong> <strong>Laboratory</strong><br />
<strong>Products</strong> <strong>Markets</strong><br />
Healthcare<br />
M22B-55<br />
Published: 30 April 2008<br />
1
Background to Study Slide 3<br />
Research Aims and Objectives Slide 5<br />
Scope of Research and Respondent Scope Slide 7<br />
Research Deliverables Slide 10<br />
Methodology followed Slide 15<br />
Benefits of Research Slide 17<br />
Frost & Sullivan Company Information and Contacts Slide 19<br />
Content
Background to Study<br />
The <strong>South</strong> <strong>African</strong> clinical laboratory products markets are in late- to mature growth phase. <strong>Clinical</strong><br />
chemistry- and immunoassay analysers are the largest contributors to revenue income in this<br />
market, followed by haematology analysers. Revenue income from urinalysis and coagulation<br />
systems are substantially lower.<br />
Technology trends followed in private laboratories indicate the use and implementation of integrated<br />
systems and consolidated workstations, while public laboratories still make use of stand-alone<br />
automated analysers. It is expected that this trend would drive the future market although growth<br />
will decrease over the forecast period.<br />
The market size for clinical laboratory products was estimated to be $83.9 million with a CAGR of<br />
4.1% from 2007 to 2013 to reach $111.2 million in 2013.<br />
3
Background to Study Slide 3<br />
Research Aims and Objectives Slide 5<br />
Scope of Research and Respondent Scope Slide 7<br />
Research Deliverables Slide 10<br />
Methodology followed Slide 15<br />
Benefits of Research Slide 17<br />
Frost & Sullivan Company Information and Contacts Slide 19<br />
Content
Research Aims and Objectives<br />
Population, economic and healthcare metrics<br />
A<br />
This report provides a strategic<br />
assessment of the healthcare industry<br />
of <strong>South</strong> Africa with a strong focus on<br />
the clinical laboratory products<br />
market. Key issues researched<br />
include:<br />
The healthcare regulatory environment<br />
B<br />
Market drivers, restraints and challenges faced in<br />
the clinical laboratory products markets<br />
C<br />
Market shares, market sizes and growth forecasts<br />
for the clinical laboratory products markets<br />
D<br />
Key success factors and recommendations within<br />
the clinical laboratory products markets<br />
E<br />
.<br />
5
Background to Study Slide 3<br />
Research Aims and Objectives Slide 5<br />
Scope of Research and Respondent Scope Slide 7<br />
Research Deliverables Slide 10<br />
Methodology followed Slide 15<br />
Benefits of Research Slide 17<br />
Frost & Sullivan Company Information and Contacts Slide 19<br />
Content
Scope of Research<br />
<strong>South</strong> <strong>African</strong> Advanced Wound Care Market<br />
MARKET SEGMENTATION:<br />
• <strong>Clinical</strong> Chemistry Analysers<br />
• Immunochemistry Analysers<br />
• Haematology Analysers<br />
• Urinalysis<br />
• Coagulation<br />
GEOGRAPHIC SCOPE<br />
• <strong>South</strong> Africa<br />
END-USER SEGMENTATION:<br />
• Private Laboratories<br />
• Public Laboratories<br />
7
Respondent Scope<br />
For Market Engineering research, Frost & Sullivan utilises tried and tested marketing techniques to provide<br />
structure to the research and an easy format to compare results across different countries, markets and over<br />
time.<br />
This project was carried out using primary research (telephone or face-to-face interviews) and secondary<br />
(published and online material) as the principle methods of data gathering. The focus of the interviews for this<br />
project were primarily the respondent types outlined in the figure below.<br />
Organisation Type Target Designations Type of Information<br />
<strong>Clinical</strong> <strong>Laboratory</strong> <strong>Products</strong><br />
Manufacturers and Suppliers<br />
Marketing Managers, Sales Directors<br />
Business Development Managers,<br />
Operations Directors,<br />
Market Demand Volumes, Key Competitive<br />
Issues, Strategic Approaches, <strong>Products</strong>, Etc.<br />
<strong>Clinical</strong> <strong>Laboratory</strong> <strong>Products</strong><br />
End-Users<br />
Private and Public <strong>Clinical</strong> Laboratories<br />
Type of equipment, volumes of tests, type of<br />
tests, Etc.<br />
Associations / Regulatory / Other<br />
Chairman, CEO, MD, Policy Directors,<br />
Departmental Managers, Industry<br />
Experts / Consultants<br />
Industry Data, Expected Market Developments,<br />
Supplier Information, Regulatory Environment,<br />
Challenges to Suppliers, Import / Export<br />
Controls<br />
8
Background to Study Slide 3<br />
Research Aims and Objectives Slide 5<br />
Scope of Research and Respondent Scope Slide 7<br />
Research Deliverables Slide 10<br />
Methodology followed Slide 15<br />
Benefits of Research Slide 17<br />
Frost & Sullivan Company Information and Contacts Slide 19<br />
Content
Research Deliverables<br />
An analysis of <strong>South</strong> Africa was carried out<br />
containing the following sections<br />
• Market engineering measurements<br />
• Country overview<br />
• Healthcare overview<br />
• Thorough country PESTLE analysis<br />
• <strong>Clinical</strong> laboratory products drivers,<br />
challenges and restraints<br />
• SA clinical laboratory products market size<br />
and growth forecasts<br />
• SA healthcare industry SWOT analysis<br />
• Key success factors for <strong>South</strong> Africa<br />
• Healthcare industry contact details<br />
R e v e n u e s ($ M illio n )<br />
<strong>Clinical</strong> <strong>Laboratory</strong> <strong>Products</strong> Market: Revenue by<br />
Product Class (<strong>South</strong> Africa), 2007<br />
35.0<br />
30.0<br />
25.0<br />
20.0<br />
15.0<br />
10.0<br />
5.0<br />
0.0<br />
26.7<br />
33.2<br />
13.4<br />
Immunochemistry Chemistry Haematology Coagulation Urinalysis<br />
Product Class<br />
7.0<br />
3.8<br />
10
Research Deliverables<br />
There are 1 326 clinical laboratories in <strong>South</strong> Africa.<br />
The National Health <strong>Laboratory</strong> Services (NHLS) –<br />
the public health service provider – comprise 250<br />
(18.9%) of the total laboratories and can be<br />
accessed nationwide.<br />
The largest private laboratory group (based on<br />
number of laboratories) – Lancet – comprises 188<br />
(14.2%) of the total laboratories while Ampath has<br />
a total of 150 (11.3%), and Pathcare 69 (5.2%).<br />
Integrated systems and the consolidation of<br />
workstations are in infancy stage and it is expected<br />
that this trend will drive the long-term growth of this<br />
market.<br />
Future growth in this market will depend greatly on<br />
the expansion of current laboratories and the<br />
founding of new laboratories, if patient volumes<br />
demand this.<br />
The replacement of current systems and<br />
incorporation of new systems are another area that<br />
will increase growth.<br />
Key Industry Challenges:<br />
Health insurance<br />
<strong>Growth</strong> expectation<br />
Key Market Drivers:<br />
Preventative disease management<br />
ARV rollout<br />
Key Market Restraints:<br />
IT infrastructure<br />
Government tenders<br />
11
Research Deliverables<br />
<strong>Clinical</strong> <strong>Laboratory</strong> <strong>Products</strong> Market: Manufacturer Market<br />
Share Analysis (<strong>South</strong> Africa), 2007<br />
23%<br />
11%<br />
21%<br />
22%<br />
23%<br />
SWOT analysis highlighted the following:<br />
STRENGTHS:<br />
Well developed market<br />
High patient demand<br />
WEAKNESSES:<br />
Skilled staff<br />
Energy crisis<br />
OPPORTUNITIES:<br />
Integration<br />
Replacement<br />
THREATS:<br />
Medical aid reimbursement<br />
Mature market<br />
Abbott Roche Beckman Coulter Siemens Other (BioRad, Scientific Group)<br />
12
Research Deliverables<br />
<strong>Clinical</strong> <strong>Laboratory</strong> <strong>Products</strong> <strong>Markets</strong>: Revenue and <strong>Growth</strong> Forecasts (<strong>South</strong> Africa), 2007<br />
120.0<br />
7.0%<br />
100.0<br />
6.0%<br />
Revenues ($ Million)<br />
80.0<br />
60.0<br />
40.0<br />
20.0<br />
5.0%<br />
4.0%<br />
3.0%<br />
2.0%<br />
1.0%<br />
Revenue <strong>Growth</strong> Rate (%)<br />
0.0<br />
2007 2008 2009 2010 2011 2012 2013<br />
Year<br />
0.0%<br />
Revenue<br />
Revenue <strong>Growth</strong> Rate<br />
13
Background to Study Slide 3<br />
Research Aims and Objectives Slide 5<br />
Scope of Research and Respondent Scope Slide 7<br />
Research Deliverables Slide 10<br />
Methodology followed Slide 16<br />
Benefits of Research Slide 18<br />
Frost & Sullivan Company Information and Contacts Slide 20<br />
Content
Methodology Followed<br />
This Research Service provides a strategic overview of the<br />
<strong>South</strong> <strong>African</strong> Healthcare industry and follows the principle of<br />
Frost & Sullivan's Market Engineering research methodology.<br />
This measurement-based methodology focuses on market<br />
measurement, analysis, forecasting, strategy development and<br />
monitoring.<br />
•The base year of 2006 was used for this research and a<br />
forecast period of seven years {from 2006} until 2012 was<br />
projected.<br />
Frost & Sullivan’s<br />
Market Engineering Research Methodology<br />
This study is based on thorough secondary and primary research principles. Extensive interviews were<br />
conducted with top level management of advanced wound care manufacturers and suppliers. Regulatory<br />
bodies also provided key market information allowing for a thorough, top-down analysis of the healthcare<br />
industry in <strong>South</strong> Africa.<br />
15
Background to Study Slide 3<br />
Research Aims and Objectives Slide 5<br />
Scope of Research and Respondent Scope Slide 7<br />
Research Deliverables Slide 10<br />
Methodology followed Slide 15<br />
Benefits of Research Slide 18<br />
Frost & Sullivan Company Information and Contacts Slide 20<br />
Content
Benefits of Research<br />
Provides excellent analysis of the external factors effecting the healthcare industry in <strong>South</strong> Africa<br />
Analysis of key market<br />
trends<br />
8<br />
1<br />
2<br />
Latest advanced wound<br />
care market revenue figures<br />
and forecasts<br />
Unique country risk rating<br />
using PESTLE data<br />
7<br />
Research<br />
Benefits<br />
3<br />
Leading advanced wound<br />
care manufacturers market<br />
share and revenue figures<br />
Thorough analysis of the<br />
regulatory environment<br />
for advanced wound care<br />
in <strong>South</strong> Africa<br />
6<br />
5<br />
Thorough comparison between<br />
public and private sector of<br />
<strong>South</strong> Africa with relevance to<br />
advanced wound care<br />
4<br />
Key market drivers,<br />
restraints and challenges<br />
for advanced wound care<br />
17
Background to Study Slide 3<br />
Research Aims and Objectives Slide 5<br />
Scope of Research and Respondent Scope Slide 7<br />
Research Deliverables Slide 10<br />
Methodology followed Slide 16<br />
Benefits of Research Slide 17<br />
Frost & Sullivan Contacts Slide 19<br />
Content
Frost & Sullivan Contacts<br />
Phil Howarth<br />
Operations Director<br />
Frost & Sullivan<br />
+27 21 680 3269<br />
phil.howarth@frost.com<br />
Keith Schlagbauer<br />
Practise Director<br />
Healthcare<br />
+27 21 680 3276<br />
keith.schlagbauer@frost.com<br />
Kate Howarth<br />
Sales Manager<br />
Frost & Sullivan<br />
+27 21 680 3261<br />
kate.howarth@frost.com<br />
Lizelle Wentzel<br />
Research Analyst<br />
Healthcare<br />
+27 21 680 3284<br />
lizelle.wentzel@frost.com<br />
19